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SUPPLEMENTARY MATERIAL & METHODS

Human samples
Lesional skin biopsy tissue was obtained at a representative psoriatic plaque, and non-lesional skin biopsy tissue was obtained adjacent to the psoriatic plaque where the lesional skin biopsy was performed. Skin biopsy tissues and relevant clinical information collected at Korea University Guro Hospital were stored at Korea University Guro Hospital Biobank. After reviewing the study by Korea University Guro Biobank Review Board committee and quality control process, de-identified samples and information were transferred to the tissue bank in the Laboratory for Investigative Dermatology at the Rockefeller University under material transfer agreement.
Immunohistochemical analyses
For immunohistochemical analysis of psoriasis skin biopsy samples, tissues were fixed in 4% buffered formaldehyde, embedded in paraffin. For H&E staining, the sections were stained with hematoxylin (Fisher Scientific) and eosin (Shandon). For immunostaining, the sections were processed for antigen retrieval with Diva Decloaker, RTU (Biocare Medical) and stained with CD3 (DAKO, clone F7.2.38, dilution 1:50), CD11c (Novocastra, clone 5D11, dilution 1:100) and K16 (Bio-Rad, clone LL025, dilution 1:40). Biotin-labeled horse anti-mouse antibodies (Vector Laboratories) were used to detect the mouse monoclonal antibodies. The staining signal was amplified with avidin-biotin complex (Vector Laboratories) and developed using chromogen 3-amino-9-ethylcarbazole (Sigma-Aldrich). Epidermal thickness and immunostaining positive cell counts were measured by computer-assisted image analysis (NIH ImageJ 1.48).
Cell counts in total psoriasis body surface area were calculated under the assumption that the number of cells in the skin biopsy tissue slide section represents the number of cells in the skin area of 5 mm (average diameter of a skin biopsy) × 6 µm (average thickness of a slide section): Cell counts in total psoriasis body surface area = (Cell counts in the slide section per 5 mm × 6 µm area) × [(Body surface area calculated from height and weight using DuBois formula, m 2 ) × (proportion of psoriasis involvement, %)].
Isolation of total RNA from skin biopsies
Frozen tissue was mechanically disaggregated before RNA extraction. RNA was extracted with
AllPrep DNA/RNA/Protein Mini Kit (Qiagen) according to the manufacturer's protocol. The
RNA yield and quality were determined with NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific) and Agilent 2100 Bioanalyzer (Agilent Technologies), respectively. 
Real-time PCR
Real
RNA microarray experiments
RNA extracted from Asian small and intermediate psoriasis skin biopsy tissues was amplified and labeled (Ovation RNA Amplification System V2, NuGEN Techologies). A total of 100 ng of biotinylated cDNA was hybridized to GeneChip Human Genome U133 Plus 2.0 Array (Affymetrix). The expression values were obtained using GCRMA algorithm (Wu et al., 2004) , while normalization across samples was carried out using quantile normalization. As the first step of data filtering, only those probe sets with at least 1 sample with expression values larger than 4 and standard deviation/SD >0.33 were kept for further analyses.
The gene expression data of Western large psoriasis skin biopsy tissues was obtained from the NIH's GEO (Gene Expression Omnibus) repository (GSE30999). The skin biopsy samples were collected from histologically confirmed Western large psoriasis patients who were enrolled into an IRB-approved Phase 3, multicenter, randomized trial protocol (ACCEPT trial) (Griffiths et al., 2010) . The platform of expression profiling was identical Affymetrix Human Genome U133 Plus 2.0 Array. The raw Affymetrix data (CEL files) were downloaded from GEO repository and expression values were obtained with the identical GCRMA algorithm (Wu et al., 2004) comparisons of interest were assessed using linear contrasts via restricted log-likelihood maximization (REML). Analysis was conducted under the general framework of limma package.
P-values from moderated (paired) t-test were adjusted for multiple hypotheses across genes using
Benjamini-Hochberg procedure. FDR < 0.05 and fold change ratio > 2 were used as cut-offs to define differentially expressed genes between lesional and non-lesional skin biopsy samples.
Pathway Analysis: The activity of entire signaling pathways for each sample was quantified by using a per-patient GSEA (Gene Set Enrichment Analysis)-like method. GSVA (Gene Set Variation Analysis) is an unsupervised sample-wise enrichment method described by Hanzelmann et al. (Hänzelmann et al., 2013) . Enrichment scores were obtained by setting the parameter z-score in gsva function available in R package. The formulation for scores evaluation was described by Lee et al. (Lee et al., 2008) . The authors proposed the linear combination of normalized expressions with weights in the combination being defined as 1/ for k being the number of genes in the pathway. This methodology was applied to obtain pathway enrichment scores in microarray analysis. These enrichment scores were used as inputs for the same linear mixed model framework, described previously for gene expressions, in order to evaluate significant differences between Asian small, Asian intermediate, and Western large psoriasis. P < 0.01 and FDR < 0.01 were used as cut-offs to define significantly increased pathway enrichment score.
Most of the statistical analysis was carried out in the R language version 2.12 (www.rproject.org), and packages were from the Bioconductor project (www.bioconductor.org). IBM SPSS Statistics Version 22 was used for stepwise linear regression modeling. Results are expressed as means ± SEM.
